Why Can’t mTOR Inhibitors Kill Cancer?

News   Oct 06, 2017 | Original story from UT Health San Antonio

 
Why Can’t mTOR Inhibitors Kill Cancer?

Mitochondrial elongation, induced by mTOR-inhibiting drugs, contributes to cell survival. Credit: Facility for Electron Microscopy Research/McGill University Department of Anatomy and Cell Biology.

 
 
 

RELATED ARTICLES

Sweet Spot of Activity in Immune System Key to Fighting Cancer

News

Scientists have shown how stimulating a specific location on the surface of immune cells can be targeted with antibodies to help in their fight against cancer.

READ MORE

Complete Skin Regeneration System of Fish Unraveled

News

Researchers at Tokyo Tech have succeeded in observing the behavior of epidermal cells for the regeneration of smooth skin without remaining scar tissue using their model animal, the zebrafish.

READ MORE

Mechanism of Scar-free Wound Healing in Fruit Fly Embryos Uncovered

News

A new study conducted by a team of researchers at the University of Toronto may help scientists and medical professionals move toward scar-free wound repair.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE